Skip to main content

Table 1 Eighteen hit compounds from preliminary screening

From: Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain

Compound

Parasite inhibition (%)

Mean ± SD

Host viability (%)

Mean ± SD

Atazanavir

93.6 ± 2.1

90.7 ± 2.8

PHA-665752

92.3 ± 3.1

80.5 ± 1.3

NVP-AEW541

91.5 ± 2.5

80.7 ± 1.2

Cyclosporine

90.8 ± 2.1

90.4 ± 1.4

GSK-J4 HCl

90.4 ± 1.4

92.2 ± 3.8

Pemetrexed disodium

88.9 ± 3.6

84.6 ± 1.5

Mocetinostat

86.5 ± 3.1

80.2 ± 3.8

AMG-208

86.4 ± 5.3

82.8 ± 1.8

CHR2797

85.6 ± 1.8

88.8 ± 6.7

H 89 2HCl

83.5 ± 1.8

89.4 ± 4.6

Blonanserin

82.1 ± 3.1

88.3 ± 5.9

Lurasidone HCl

80.4 ± 1.5

86.9 ± 1.7

ZM 323881 HCl

79.9 ± 1.4

85.5 ± 5.4

Pamidronate disodium

79.6 ± 1.5

80.8 ± 1.4

Cyproheptadine HCl

79.2 ± 3.5

90.6 ± 1.2

Entinostat

75.7 ± 2.2

81.6 ± 1.5

Medetomidine HCl

70.8 ± 1.5

90.5 ± 4.4

Lafutidine

70.6 ± 2.5

92.7 ± 5.6

  1. Abbreviation: SD, standard deviation